75N93022F00003↗
PPD Development LP received this contract from National Institutes of Health Niaid, National Institutes of Health: $0 obligated so far for health r&d services; health care - other; applied research. Its period of performance ended 2024-03-22.
Key facts · data as of Oct 23, 2026
- Recipient
- PPD Development LP
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Obligated to date
- $0
- Potential value
- $2.33M
- Ends
- 2024-03-22
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.
Cite this page: SpendQuery, Award 75N93022F00003, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_75N93022F00003_7529_75N93021D00035_7529
PPD Development LP: all federal awards · Department of Health and Human Services: spending · National Institutes of Health Niaid: what it buys
THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE)
What it is
- Product or service
- Health R&D Services; Health Care - Other; Applied Research (PSC AN42)
- Industry
- Research and Development in Biotechnology (Except Nanobiotechnology) (NAICS 541714)
- Contracting office
- National Institutes of Health Niaid (75N930)
- Competition
- Full and open competition
- Pricing
- Cost no fee
- How it was bought
- Single-award IDIQ · under 75N93021D00035
- Where the work is
- Montgomery, MD · district MD-08
- Topics
- opioids
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.
Every action
1 action since 2023-08-31. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2023-08-31 | P00001 | Administrative change | $0 | THE CONTINUUM OF CARE IN HOSPITALIZED PATIENTS WITH OPIOID USE DISORDER AND INFECTIOUS COMPLICATIONS OF DRUG USE (CHOICE) |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗